NSE: CLEAN · BSE: 543318 · ISIN INE227W01023
Clean Science and Technology Limited stock analysis
Clean Science and Technology Limited ranks #872 in the TickerSutra evidence-ranked universe with a score of 59/100 and 93% data confidence. The latest captured fundamentals show ROCE of 20.7%, quarterly sales growth of 10.5% and quarterly profit growth of 4.7%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- ROCE is 20.7%
- Low debt/equity of 0×
- Institutional ownership is rising
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- Operating margin has compressed materially
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹685cr | ₹300cr | ₹228cr | 44.0% |
| 2023 | ₹936cr | ₹403cr | ₹295cr | 43.0% |
| 2024 | ₹791cr | ₹332cr | ₹244cr | 42.0% |
| 2025 | ₹967cr | ₹388cr | ₹264cr | 40.0% |
| 2026 | ₹957cr | ₹356cr | ₹230cr | 37.0% |
| TTM | ₹982cr | ₹352cr | ₹233cr | 36.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, investment in wholly owned subsidiary.
RoutineAcquisition (including agreement to acquire)-XBRLNSE · 23 Sept 2026 · Structured filingClean Science and Technology Limited has informed the Exchange regarding Acquisition (including agreement to acquire)
Clean Science and Technology Limited has informed the Exchange regarding Acquisition (including agreement to acquire)
Open original XBRL sourceEnclosed are the details
MANAGEMENT COMMENTARY
Signals from filed documents
The demand environment continues to be steady. On consolidated business performance, the HALS scaleup continues to drive operating leverage and sustainable profit improvement. HALS is now 22% of our sales, and we have been able to Clean Science and Technology Limited August 01, 2026 Page 3 of 17 derisk our reliance on the top 4 legacy products by moderating their share from 85% in Q4 FY23 to 60% this quarter.
Last year, we were hovering under 40%. Was there any benefit of low-cost acetone we were carrying, and price increase has helped us, and lower raw material cost is benefiting on gross profit margin or do you think this 43%, 45% of gross profit margin in this segment is sustainable? Siddharth Sikchi: I think it should be sustainable, and we had no real advantage of cheap raw material.
And how much was the contribution of the products beyond 701 and 770? Siddharth Sikchi: In terms of price realization, Sanjesh, the product mix has improved. From 770, 622, we have now moved to the higher grades.
Minimum Remuneration Notwithstanding anything to the contrary herein contained where in any financial year during the tenure of Mr. Krishnakumar Satyanarain Saboo, the Company has no profits or its profits are inadequate, the Company will pay remuneration by way of salary, perquisites, benefits, allowances, performance linked bonus as may be approved by the Board subject to the limits prescribed under Schedule V of t
And because we would be making additional capexes on some of these products, so we thought both of us Clean Science and Technology Limited August 01, 2026 Page 8 of 17 decided to enter into a longer -term contract for a minimum period of 5 years where we will be supplying their needs of these products, and that is where it is. So it's a very, very interesting collaboration for us, because this gives us assured volume
And second question, in terms of HALS, you mentioned that this quarter was -- there was almost 50% exports and 50% domestic, and the component of exports has increased tremendously. Is it because of the high -grade HALS that we are manufacturing wh ere we've been able to sell into the export market and where now there we are seeing a good amount of traction? Siddharth Sikchi: See, the point is, over the last 1 year,
He has more than 27 years’ experience in the chemical industry. He is engaged in day-to-day operational activities having expertise in project procurement, general management and administration, regulatory approvals, compliances, identifying, reviewing and monitoring CSR projects. Terms and conditions of Re- appointment He was appointed as Whole-Time Director of the Company.
And just on the standalone side, what could be the domestic export mix for the quarter, if you may help with that number, please? And lastly, if you can guide on the capex, what should we take as an annual run rate going ahead, given there could be some capacity expansion plans there? Siddharth Sikchi: Actually, we have not worked out in that detail, but it's not going to be too much.
So yes, I think there would be a delay, and we expect the plant to start in November-ish. So that will be commercial production or trials in November? Siddharth Sikchi: Commercialization.
Members may join the AGM through the VC/OAVM facility 30 minutes before and up to 30 minutes after the scheduled commencement of the Meeting by following the procedure set out in this Notice. The VC/OAVM facility will be available to up to 1,000 Members on a first-come, first-served basis; however, this restriction shall not apply to large shareholders (holding 2% or more of the Company’s share capital), Promoters, I
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…